Concepedia
Statistics
Publications
14
Citations
384
H-Index
13
Active since
2012
Affiliations
Charles University(Current)
University of Hradec Králové
Duke University
The University of Sydney
Hana Jansová is an author at Charles University specializing in pharmacology, medicine, and iron chelation therapy.
Publications per year
2012–2019
Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells
Anna Vávrová, Hana Jansová, Eliška Macková et al. · PLoS ONE · 2013 · 71 citations · Full text
Medicine, Oncology, Pharmacology +14
Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: Novel iron chelators with selective antiproliferative action
Eliška Macková, Kateřina Hrušková, Petra Bendová et al. · Chemico-Biological Interactions · 2012 · 45 citations
Pharmacy, Medicinal Chemistry, Pharmacology +11
Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents
Vít Šesták, Ján Stariat, Jolana Cermanová et al. · Oncotarget · 2015 · 45 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +8
Quantitative Analysis of the Anti-Proliferative Activity of Combinations of Selected Iron-Chelating Agents and Clinically Used Anti-Neoplastic Drugs
Eliška Potůčková, Hana Jansová, Miloslav Macháček et al. · PLoS ONE · 2014 · 30 citations · Full text
Medicine, Oncology, Pharmacology +9
Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury
Hana Jansová, Miloslav Macháček, Qin Wang et al. · Free Radical Biology and Medicine · 2014 · 30 citations
Medicine, Cardiology, Pharmacology +15
1–5 of 14